APP Pharmaceuticals, Inc. 4
4 · APP Pharmaceuticals, Inc. · Filed Sep 15, 2008
Insider Transaction Report
Form 4
Themba 2005 Trust II
10% Owner
Transactions
- Disposition to Issuer
Common Stock
2008-09-10−34,899,338→ 0 total
Footnotes (1)
- [F1]Disposed of pursuant to the Agreement and Plan of Merger, dated as of July 6, 2008, among Fresenius SE, Fresenenius Kabi Pharmaceuticals Holding, Inc. (formerly Frensenius Kabi Pharmaceuticals Holding LLC), Fresenius Kabi Pharmaceuticals, LLC ("Merger Sub") and APP Pharmaceuticals, Inc. ("APP"), whereby Merger Sub merged into APP with APP continuing as the surviving company and an indirect wholly owned subsidiary of Fresenius SE, in exchange for (x) an amount in cash equal to $23.00 plus (y) a contingent value right issued by Holdco.